📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Macrophage Reprogramming with Anti-miR223-Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential. (2022)

First Author: López-Cuevas P
Attributed to:  BrisEngBio: From Synthetic to Engineering Biology at Bristol funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/advs.202202717

PubMed Identifier: 36314048

Publication URI: http://europepmc.org/abstract/MED/36314048

Type: Journal Article/Review

Volume: 9

Parent Publication: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Issue: 35

ISSN: 2198-3844